-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
AbCellera Biologics Inc. quarterly/annual Return On Equity history and change rate from 2020 to Q3 2025.
- AbCellera Biologics Inc. Return On Equity for the quarter ending 30 Sep 2025 was -17 %, a 7.82% decline year-over-year.
- AbCellera Biologics Inc. annual Return On Equity for 2024 was -14.9 %, a 20.5% decline from 2023.
- AbCellera Biologics Inc. annual Return On Equity for 2023 was -12.4 %, a 196% decline from 2022.
- AbCellera Biologics Inc. annual Return On Equity for 2022 was 12.9 %, a 17.7% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)